Loading clinical trials...
Loading clinical trials...
Actual studies suggest that a calcium activated chlorid channel (TMEM16A) may play a relevant role in the pathogenesis of pulmonary arterial hypertension (PAH). The inhibition of this channel led to p...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Medical University of Graz
Collaborators
NCT05584722 · Idiopathic Pulmonary Arterial Hypertension, Heritable Pulmonary Arterial Hypertension, and more
NCT06587074 · Idiopathic Pulmonary Arterial Hypertension
NCT05493371 · Idiopathic Pulmonary Arterial Hypertension
NCT05767918 · Pulmonary Arterial Hypertension, Idiopathic Pulmonary Arterial Hypertension, and more
NCT02565030 · Chronic Thromboembolic Pulmonary Hypertension, Idiopathic Pulmonary Arterial Hypertension
Medical University of Graz
Graz
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions